BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28160858)

  • 21. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
    Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
    Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.
    Chu B; Liu F; Li L; Ding C; Chen K; Sun Q; Shen Z; Tan Y; Tan C; Jiang Y
    Cell Death Dis; 2015 Mar; 6(3):e1686. PubMed ID: 25766325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways.
    Shyur LF; Lee SH; Chang ST; Lo CP; Kuo YH; Wang SY
    Phytomedicine; 2010 Dec; 18(1):16-24. PubMed ID: 20637573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p38 MAPK and ERK1/2 pathways are involved in the pro-apoptotic effect of notoginsenoside Ft1 on human neuroblastoma SH-SY5Y cells.
    Gao B; Shi HL; Li X; Qiu SP; Wu H; Zhang BB; Wu XJ; Wang ZT
    Life Sci; 2014 Jul; 108(2):63-70. PubMed ID: 24857982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
    Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
    Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2α-Hydroxyursolic Acid Inhibited Cell Proliferation and Induced Apoptosis in MDA-MB-231 Human Breast Cancer Cells through the p38/MAPK Signal Transduction Pathway.
    Jiang X; Li T; Liu RH
    J Agric Food Chem; 2016 Mar; 64(8):1806-16. PubMed ID: 26872218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS.
    Woo CC; Hsu A; Kumar AP; Sethi G; Tan KH
    PLoS One; 2013; 8(10):e75356. PubMed ID: 24098377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective anticancer activity of hirsutine against HER2‑positive breast cancer cells by inducing DNA damage.
    Lou C; Yokoyama S; Saiki I; Hayakawa Y
    Oncol Rep; 2015 Apr; 33(4):2072-6. PubMed ID: 25672479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.
    Rabi T; Banerjee S
    Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
    Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
    Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyporus umbellatus inhibited tumor cell proliferation and promoted tumor cell apoptosis by down-regulating AKT in breast cancer.
    Tan XL; Guo L; Wang GH
    Biomed Pharmacother; 2016 Oct; 83():526-535. PubMed ID: 27447121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eucalrobusone C suppresses cell proliferation and induces ROS-dependent mitochondrial apoptosis via the p38 MAPK pathway in hepatocellular carcinoma cells.
    Jian KL; Zhang C; Shang ZC; Yang L; Kong LY
    Phytomedicine; 2017 Feb; 25():71-82. PubMed ID: 28190473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades.
    Shim HY; Park JH; Paik HD; Nah SY; Kim DS; Han YS
    Anticancer Drugs; 2007 Jul; 18(6):649-57. PubMed ID: 17762393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
    Lee B; Kim CH; Moon SK
    FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
    Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.
    Park S; Han SH; Kim HG; Jeong J; Choi M; Kim HY; Kim MG; Park JK; Han JE; Cho GJ; Kim MO; Ryoo ZY; Choi SK
    Mol Cell Probes; 2019 Oct; 47():101440. PubMed ID: 31445970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.